<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="164669">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01715597</url>
  </required_header>
  <id_info>
    <org_study_id>SNUBH_GO_016</org_study_id>
    <nct_id>NCT01715597</nct_id>
  </id_info>
  <brief_title>Study on the Effect of Intravenous Ascorbic Acid on Intraoperative Blood Loss in Women With Uterine Myoma</brief_title>
  <official_title>Placebo-controlled,Doubled,Randomized Trial Evaluating the Effect of Intravenous Ascorbic Acid on Intraoperative Blood Loss in Women Undergoing Laparoscopic Myomectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <authority>Korea: Institutional Review Board</authority>
    <authority>Korea: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators want to know whether the intravenous ascorbic acid would reduce the blood
      loss during laparoscopic myoma surgery. The investigators randomized patients into
      intravenous ascorbic acid group and placebo group and examined the blood loss in both
      groups.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Anticipated">March 2014</completion_date>
  <primary_completion_date type="Anticipated">March 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>blood loss</measure>
    <time_frame>during  laparoscopic myomectomy</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <other_outcome>
    <measure>time of operation</measure>
    <time_frame>during laparoscopic myomectomy</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>the amount of transfusion</measure>
    <time_frame>during laparoscopic myomectomy</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>the difference of hemoglobin</measure>
    <time_frame>postoperative day 1</time_frame>
    <safety_issue>No</safety_issue>
    <description>postoperative day 1 hemoglobin - preoperative hemoglobin + hemoglobin increased by transfusion (hemoglobin 1 per RBC 1 pack transfusion)</description>
  </other_outcome>
  <other_outcome>
    <measure>acute urinary retention</measure>
    <time_frame>2days after the operation</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Uterine Leiomyoma</condition>
  <arm_group>
    <arm_group_label>ascorbic acid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ascorbic acid 2g in normal saline 500ml IV start 2hours before the operation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Normal saline 500ml IV infusion for 2hour</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ascorbic acid</intervention_name>
    <description>ascorbic acid 2g in normal saline 500ml IV start 30min before the operation and infusion for 2 hour</description>
    <arm_group_label>ascorbic acid</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  uterine myoma

          -  be planning to laparoscopic myomectomy

          -  images ; the number of myoma &lt;4

          -  images ; the diameter of the largest myoma &lt;9cm

        Exclusion Criteria:

          -  be planning other surgery in addition to laparoscopy

          -  clinically significant coagulation abnormality
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>kiding kim, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Bundang Hospital,Gyeongg-ido,Republic of Korea</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kidong kim, M.D.</last_name>
    <phone>82-31-787-7262</phone>
    <email>kidong.kim.md@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Gyeongg-ido</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>kidong kim, M.D</last_name>
      <email>kiding.kim.md@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 24, 2013</lastchanged_date>
  <firstreceived_date>October 22, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Kidong Kim</investigator_full_name>
    <investigator_title>Assistant professor in department of OBGY</investigator_title>
  </responsible_party>
  <keyword>uterine leiomyoma</keyword>
  <keyword>laparoscopic myomectomy</keyword>
  <keyword>intraoperative blood loss</keyword>
  <keyword>ascorbic acid</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Leiomyoma</mesh_term>
    <mesh_term>Myofibroma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Ascorbic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
